Back

15-month results of the MASTER DAPT trial.

29 August 2022 (08:48 - 08:58)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 8 Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

14 More presentations in this session

Presentation thumbnail
ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up.
Professor S. Bangalore (New York, US)
Slides Video
Presentation thumbnail
Discussant review - ISCHEMIA-CKD EXTEND.
Professor D. Bhatt (New York City, US)
Slides Video
Presentation thumbnail
Panel discussion - ISCHEMIA-CKD EXTEND.
Video
Presentation thumbnail
Discussant review - MASTER DAPT.
Professor S. Schuepke (Munich, DE)
Slides Video
Presentation thumbnail
Panel discussion - MASTER DAPT.
Video

Access the full session

Session thumbnail
HOT LINE SESSION 8
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 08:48 CET
You may be interested in
thumbnail
Congress Presentation
A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials
29 August 2025
thumbnail
Congress Presentation
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
31 August 2025
thumbnail
Congress Presentation
Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3
31 August 2024
thumbnail
Congress Presentation
Timing of bleeding and ischemic events after PCI in high and very high bleeding risk patients treated with 1-month DAPT: a patient-level pooled analysis of clinical trials
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources